dendriticcellbased_immunotherapy_evokes_potent_antitumor_immune_responses_in_cd105_human_renal_cancer_stem_cells.mol_carcinog10.1002mc_资料4.Image.Marked.pdf

RESEARCH ARTICLE Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells† Xiao-Fei Zhang1,2#, De-sheng Weng1,2#, Ke Pan1,2, Zi-Qi Zhou1,2, Qiu-zhong Pan1,2, 1,2 2 1,2 1,2 2 Jing-Jing Zhao , Yan Tang , Shan-Shan Jiang , Chang-Long Chen , Yong-Qiang Li ， 1,2 3 3 4 3* Hong-Xia Zhang , Alfred E. Chang , Max S. Wicha , Yi-Xin Zeng , Qiao Li and Jian-Chuan Xia1,2* 1State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People’s Republic of China 2Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou 510060, People’s Republic of China 3University of Michigan Comprehensive Cancer Center; Ann Arbor, MI USA 4Beijing Hospital, Beijing, China #These authors contributed equally to this work. †This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: [10.1002/mc.22697] Additional Supporting Information may be found in the online version of this article. Received 17 January 2017; Revised 15 May 2017; Accepted 13 June 2017 Molecular Carcinogenesis This article is protected by copyright. All rights reserved